The Markers of Glutamate Metabolism in Peripheral Blood Mononuclear Cells and Neurological Complications in Lung Cancer Patients

Table 1

The content of glutamate and activities of GLS, GDH, and GAD in PBMC of lung cancer patients during chemotherapy. ; , and .

	Baseline	After 6-month chemotherapy
Glutamate (nmol/mg protein) median; minimum–maximum	1.03; 0–5543.42	253.5; 0–41615.30
Glutaminase (mU/mg protein) median; minimum–maximum	0.42; 0–91.33	0.089; 0–31.97
Glutamate dehydrogenase (mU/mg protein) median; minimum–maximum	3.67; 1.57–1594.61	15.99; 4.08–3185.02
Glutamate decarboxylase (U/mg protein) median; minimum–maximum	0.85; 0–33.25	0.93; 0–79.98